2019
DOI: 10.1016/j.avsg.2018.09.024
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of Clinical Outcomes between Endovascular Therapy with Self-Expandable Nitinol Stent and Femoral–Popliteal Bypass for Trans-Atlantic Inter-Society Consensus II C and D Femoropopliteal Lesions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
4
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 18 publications
1
4
0
Order By: Relevance
“…The 2-year results of the present study showed similar patency rates and freedom from TLR for the stent and bypass groups. 17 This was in contrast to most retrospective data 2426 but in accordance with other 1-year RCT results. 7,8 The final analysis of the 4-year results of our study shows that the long-term outcomes of NS are significantly different to VBP in several aspects.…”
Section: Discussionsupporting
confidence: 89%
“…The 2-year results of the present study showed similar patency rates and freedom from TLR for the stent and bypass groups. 17 This was in contrast to most retrospective data 2426 but in accordance with other 1-year RCT results. 7,8 The final analysis of the 4-year results of our study shows that the long-term outcomes of NS are significantly different to VBP in several aspects.…”
Section: Discussionsupporting
confidence: 89%
“…Previous studies comparing OSB with PTA/S reported that bypass surgery resulted in a three year patency rate of 74% vs. 60% for endovascular treatment, and a five year patency 69.4% vs. 45.2%, respectively. 23,24 A meta-analysis comparing OSB and PTA/S for the treatment of femoropopliteal arterial disease showed that an endovascular first approach may be advisable in patients with significant comorbidity, whereas for fit patients with probable longer term survival, a bypass procedure should be offered as first line interventional treatment. 25 The randomised BASIL trial and findings from Darling et al raise the possibility that patients may benefit from a bypass first strategy as opposed to an angioplasty first strategy.…”
Section: Discussionmentioning
confidence: 99%
“…Compared to our result, in most retrospective studies for the treatment of long femoropopliteal lesions, bypass procedures had remarkably higher primary (75 -80%) and secondary patency rates (85 -94%) at 2 years. However, in the majority of trials the percentage of claudicants was higher and the mean lesion lengths were shorter, except for the results of Veraldi et al with 79% CLTI patients [7][8][9][10] .…”
Section: Discussionmentioning
confidence: 87%
“…For longer lesions bypass surgery is recommended, but this is not based on a high level of evidence and was challenged by several trials. Three recent randomized controlled trials (RCT) showed noninferiority of endovascular therapy for long femoropopliteal lesions (TASC II type C and D) compared to bypass surgery regarding primary patency and freedom from target lesion revascularization (TLR) [4][5][6] , which is in contrast to the majority of retrospective studies [7][8][9][10] . The revascularization techniques in the three RCTs varied considerably.…”
Section: Main Text Introductionmentioning
confidence: 99%